CHOLANGIOCARCINOMA NON-RESECTABLE
Clinical trials for CHOLANGIOCARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could blocking a liver artery before surgery help fight bile duct cancer?
Disease control Not yet recruitingThis study tests a new approach for people with a hard-to-treat type of bile duct cancer. Before surgery, doctors will block the artery that feeds the tumor to encourage new blood vessels to grow, making it safer to remove the cancer. The goal is to see if this helps people live …
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
Can simple blood tests predict bile duct cancer outcomes?
Knowledge-focused Not yet recruitingThis study looks at whether blood tests that detect cancer DNA (ctDNA) and patient-reported quality of life can help predict how bile duct cancer will progress and how well treatment is working. Researchers will collect blood samples and questionnaires from 300 patients with cura…
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC